Does TAFASITAMAB Cause Respiratory failure? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Respiratory failure have been filed in association with TAFASITAMAB (MONJUVI). This represents 1.0% of all adverse event reports for TAFASITAMAB.
14
Reports of Respiratory failure with TAFASITAMAB
1.0%
of all TAFASITAMAB reports
5
Deaths
11
Hospitalizations
How Dangerous Is Respiratory failure From TAFASITAMAB?
Of the 14 reports, 5 (35.7%) resulted in death, 11 (78.6%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Respiratory failure Listed in the Official Label?
Yes, Respiratory failure is listed as a known adverse reaction in the official FDA drug label for TAFASITAMAB.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
Covid-19 (96)
General physical health deterioration (75)
Pneumonia (66)
Febrile neutropenia (64)
Drug ineffective (62)
What Other Drugs Cause Respiratory failure?
PREDNISONE (2,299)
CYCLOPHOSPHAMIDE (2,096)
RITUXIMAB (1,838)
TACROLIMUS (1,758)
METHOTREXATE (1,685)
DEXAMETHASONE (1,603)
MYCOPHENOLATE MOFETIL (1,469)
METHYLPREDNISOLONE (1,442)
PREDNISOLONE (1,346)
VINCRISTINE (1,120)
Which TAFASITAMAB Alternatives Have Lower Respiratory failure Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR